PCSK9 gene-silencing oligonucleotides (Idera Pharmaceuticals)

N/A

Report date: 2025/05/14 11:14:12

Base Information

Drug NamePCSK9 gene-silencing oligonucleotides (Idera Pharmaceuticals)

Drug Alias NamePCSK9 targeting GSOs (Idera Pharmaceuticals)

ClassificationCell and gene therapy > Gene therapy > mRNASmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense

Mechanisms of ActionProprotein convertase subtilisin kexin type 9 inhibitors

TargetsProprotein convertase subtilisin kexin type 9

Therapy Area/IndicationsHypercholesterolemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAceragen Inc

China Registration ClassN/A

Develop Information

Active CompaniesAceragen Inc

Inactive CompaniesN/A

Active IndicationsHypercholesterolemia

Inactive IndicationsN/A

Other Information

ATC CodeN/A